Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Chenguang Medical Technologies Co Gross Margin %?
Shanghai Chenguang Medical Technologies CoBJSE:920300 53 Gross Margin % is 41.14% as of Mar. 2026, which is 3% above its 10-year median of 40.06. GuruFocus rates BJSE:920300 with a GF Score™ of 53/100 and a GF Value™ of ¥6.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 3,001 Industrial Products companies, Shanghai Chenguang Medical Technologies Co ranks better than 92.77% on this metric.
BJSE:920300's Gross Margin % is ranked better than 92.77% of 3001
companies
in the Industrial Products industry
Industry Median: 26.87
vs BJSE:920300: 55.02
Shanghai Chenguang Medical Technologies Co had a gross margin of 41.14% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Shanghai Chenguang Medical Technologies Co (BJSE:920300) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai Chenguang Medical Technologies Co had a gross margin of 41.14% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai Chenguang Medical Technologies Co Gross Margin % Related Terms
Shanghai Chenguang Medical Technologies Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Chenguang Medical Technologies Co Gross Margin % Chart
Shanghai Chenguang Medical Technologies Co Annual Data
For the Electrical Equipment & Parts subindustry, Shanghai Chenguang Medical Technologies Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Chenguang Medical Technologies Co Gross Margin % vs Industrial Products Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai Chenguang Medical Technologies Co (BJSE:920300) has a Gross Margin % of 41.14% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. This is near median its historical median of 40.06. Over the past decade, Shanghai Chenguang Medical Technologies Co's Gross Margin % has ranged from 31.57 to 55.02. According to the industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #217 out of 3001 companies in the Industrial Products industry, placing it in the top 7.2%.
Is Shanghai Chenguang Medical Technologies Co's Gross Margin % too high?
Shanghai Chenguang Medical Technologies Co's current Gross Margin % of 41.14% is near median its 10-year median of 40.06. Over the past 10 years, this metric has ranged from a low of 31.57 to a high of 55.02. The Industrial Products industry median Gross Margin % is 26.87. Shanghai Chenguang Medical Technologies Co's value of 41.14% is 53.1% above this industry median. Based on the distribution chart, Shanghai Chenguang Medical Technologies Co ranks #217 out of 3001 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Chenguang Medical Technologies Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Chenguang Medical Technologies Co's Gross Margin % compare to VRT and BE?
According to the Industrial Products industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #217 out of 3001 companies for Gross Margin %. This places Shanghai Chenguang Medical Technologies Co in the top 7% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 26.87. Shanghai Chenguang Medical Technologies Co's value of 41.14% is 53.1% above this benchmark. Historically, Shanghai Chenguang Medical Technologies Co's own Gross Margin % has ranged from 31.57 to 55.02 over the past decade. While the company's 10-year median is 40.06 vs. the industry median of 26.87, Shanghai Chenguang Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for an Industrial Products company?
The median Gross Margin % among Industrial Products companies is 26.87, based on 3,001 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Chenguang Medical Technologies Co's current Gross Margin % of 41.14% is 53.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. For the Industrial Products industry, the median Gross Margin % is 26.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Chenguang Medical Technologies Co's current Gross Margin % is 41.14%, which is near median its own 10-year median of 40.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Chenguang Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co (BJSE:920300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥6.57, compared to a current price of ¥9.47 — trading 44.1% above its estimated fair value. The current Gross Margin % is 41.14%, which is near median its 10-year median of 40.06 and 53.1% above the Industrial Products industry median of 26.87. Shanghai Chenguang Medical Technologies Co's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai Chenguang Medical Technologies Co (BJSE:920300), the current Gross Margin % is 41.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Chenguang Medical Technologies Co (BJSE:920300) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co stock appears to be overvalued.
The current stock price of ¥9.47 is trading 44.1% above its estimated GF Value™ of ¥6.57.
GuruFocus considers Shanghai Chenguang Medical Technologies Co to be Significantly Overvalued.
Key valuation signals for BJSE:920300:
Gross Margin %: 41.14% (near median its 10-year median of 40.06)
GF Value™: ¥6.57 vs. price of ¥9.47 (44.1% above fair value)
Industry Position: 53.1% above the Industrial Products median (#217 of 3001)
No single metric tells the full story. See the BJSE:920300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
53GF Score
Get the complete analysis for BJSE:920300
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920300 has been successfully added to your 
